Aria CV

Private

Saint Paul, MinnesotaHealthcare & Life Scienceshttps://ariacv.com/

Last Round

Series C

Aug 18, 2025

Est. Valuation

$68.6M

Total Funding Raised

$57.32M

Company Overview

Aria CV is a medical device company that develops implantable systems for the treatment of pulmonary hypertension.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

pulmonary arterial hypertensionPAHimplantable medical devicecardiovascular devicemedtechFDA breakthrough designationhemodynamicsright ventricular afterloadinterventional cardiologyclinical stage biotechpulmonary artery compliancetherapeutic implant

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aria CV Comps

Public and private peers based on sector, stage, and business model.

Aria CV comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aria CV Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Aug 18, 2025
Debt	Jul 1, 2022
Accelerator	Jun 15, 2021
Series B	Feb 25, 2020
Series A Extension	Mar 12, 2018
Series A	Jul 1, 2015

View all Funding Rounds

Key People

Founding team and executive leadership

Peter DeLange

Chief Technology Officer

Executive Team

Aria CV Investors

Notable investors and investment history

Aria CV investors
Investor	Rounds
Cedar Point Capital, LLC	Series A
Xeraya Capital	Series B
CHV	Series B, Series A
KOFA Healthcare	Series C
Cedar Point Capital	Series B, Series A
BioStar Capital	Series C, Series B
Longview Partners	Series B

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 25, 2020
$31M round led by Xeraya Capital.

View all signals

Aria CV Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Aria CV Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aria CV's valuation, stock price, and market status.

Firmographic Details

HeadquartersSaint Paul, Minnesota

Employee Range13

Year Founded2010

Last FundingAug 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.